Aroon Hingorani

Aroon Hingorani

University College London

H-index: 131

Europe-United Kingdom

About Aroon Hingorani

Aroon Hingorani, With an exceptional h-index of 131 and a recent h-index of 90 (since 2020), a distinguished researcher at University College London, specializes in the field of Genomics, drug development, cardiovascular diseases, multi-morbidity.

His recent articles reflect a diverse array of research interests and contributions to the field:

APOEε4 carriage associates with improved myocardial performance from adolescence to older age

Comparing screening based on the NHS Health Check and Polypill Prevention Programmes in the primary prevention of heart attacks and strokes

Proteogenomic data integration reveals CXCL10 as a potentially downstream causal mediator for IL-6 signaling on atherosclerosis

Prioritising genetic findings for drug target identification and validation

The effect of cholesteryl ester transfer protein (CETP) activity on cardiometabolic and non-cardiometabolic diseases in East-Asian and European populations

Mapping the aetiological foundations of the heart failure spectrum using human genetics

Biological and functional multimorbidity—from mechanisms to management

Genome-wide association analysis reveals insights into the molecular aetiology underlying dilated cardiomyopathy

Aroon Hingorani Information

University

Position

___

Citations(all)

155509

Citations(since 2020)

64282

Cited By

119149

hIndex(all)

131

hIndex(since 2020)

90

i10Index(all)

336

i10Index(since 2020)

261

Email

University Profile Page

Google Scholar

Aroon Hingorani Skills & Research Interests

Genomics

drug development

cardiovascular diseases

multi-morbidity

Top articles of Aroon Hingorani

APOEε4 carriage associates with improved myocardial performance from adolescence to older age

BMC Cardiovascular Disorders

2024/3/21

Comparing screening based on the NHS Health Check and Polypill Prevention Programmes in the primary prevention of heart attacks and strokes

Journal of Medical Screening

2024/3/15

Proteogenomic data integration reveals CXCL10 as a potentially downstream causal mediator for IL-6 signaling on atherosclerosis

Circulation

2024/2/27

Prioritising genetic findings for drug target identification and validation

2024/1/26

The effect of cholesteryl ester transfer protein (CETP) activity on cardiometabolic and non-cardiometabolic diseases in East-Asian and European populations

Atherosclerosis

2023/8/1

Biological and functional multimorbidity—from mechanisms to management

2023/7

Genome-wide association analysis reveals insights into the molecular aetiology underlying dilated cardiomyopathy

Nature genetics

2022/6

How to assess pharmacogenomic tests for implementation in the NHS in England

2023/6/14

Performance of polygenic risk scores in screening, prediction, and risk stratification: secondary analysis of data in the Polygenic Score Catalog

BMJ medicine

2023

Estimating dementia risk using Multifactorial prediction models

JAMA Network Open

2023/6/1

Comparing the effect profile of CETP in individuals of East Asian and European ancestries

medRxiv

2023

Genome-wide association meta-analysis of spontaneous coronary artery dissection identifies risk variants and genes related to artery integrity and tissue-mediated coagulation

Nature Genetics

2023/6

Identifying and visualising multimorbidity and comorbidity patterns in patients in the English National Health Service: a population-based study

The Lancet Digital Health

2023/1/1

Utility of polygenic risk scores in UK cancer screening: a modelling analysis

2023/6/1

Two-year recall for people with no diabetic retinopathy: a multi-ethnic population-based retrospective cohort study using real-world data to quantify the effect

British Journal of Ophthalmology

2023/12/1

A machine learning model to aid detection of familial hypercholesterolemia

JACC: Advances

2023/6/1

NMR metabolomic modelling of age and lifespan: a multi-cohort analysis

medRxiv

2023/11/8

Druggable proteins influencing cardiac structure and function: Implications for heart failure therapies and cancer cardiotoxicity

Science advances

2023/4/26

The impact of risk stratification by polygenic risk and age on breast cancer screening in women aged 40–49 years: a modelling study

The Lancet

2023/11/1

See List of Professors in Aroon Hingorani University(University College London)